Johnson Fistel Investigates Potential Breaches of Fiduciary Duty in Connection with the Proposed Acquisition of Organon by Sun Pharmaceutical

SAN DIEGO, April 27, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Organon & Co. (NYSE: OGN) breached their fiduciary duties in connection with the proposed sale of the company to Sun Pharmaceutical.